Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis.
The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS).
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab.
Activities of the European multiple sclerosis platform.
Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: A protective role for erythropoietin.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Lysophospholipids and their receptors in the central nervous system.
[Disease modifying drugs in multiple sclerosis and pregnancy.]
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Default Network Connectivity Is Linked to Memory Status in Multiple Sclerosis.
Pages
« first
‹ previous
…
399
400
401
402
403
404
405
406
407
…
next ›
last »